<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04105140</url>
  </required_header>
  <id_info>
    <org_study_id>UESTC-neuSCAN-44</org_study_id>
    <nct_id>NCT04105140</nct_id>
  </id_info>
  <brief_title>Oxytocin Effects on the Prosocial Learning</brief_title>
  <official_title>Oxytocin Effects on the Prosocial Learning</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Electronic Science and Technology of China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Electronic Science and Technology of China</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate whether intranasal oxytocin (24 IU) treatment can influence prosocial learning
      behavior in males.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a double-blind, within-subject, placebo controlled design, investigators plan to
      investigate the effect of oxytocin treatment on prosocial learning. Before the
      self-administration, participants need to finish several questionnaires including IRI, AAS,
      BASBIS, SPSRQ, SES, PTM, STAI, BDI, ASQ and PNAS. They would finish the PANAS again before
      the scanning.

      Participants are informed that they perform the reward learning task either for themselves,
      another (unknown) person or no one (control). In the probabilistc reward learning task,
      associations with two stimuli with different reward probabilities are learned via monetary
      feedback (reward ￥1 or no reward ￥0). After the experiment, participants need to finish the
      PANAS.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Actual">August 10, 2018</completion_date>
  <primary_completion_date type="Actual">August 10, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neural processing during feedback based on prosocial learning assessed by fMRI scanner</measure>
    <time_frame>1 hour</time_frame>
    <description>fMRI BOLD indices of neural processing learning related brain regions will be compared between the treatment administrations.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Behavioral learning performance measured by E-prime</measure>
    <time_frame>1 hour</time_frame>
    <description>Learning performance will be compared between the treatment administrations by calculating the accuracy of learning.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>male oxytocin group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>male subjects with oxytocin treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>male placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>male subjects with placebo treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxytocin</intervention_name>
    <description>intranasal administration of oxytocin (24 IU)</description>
    <arm_group_label>male oxytocin group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>intranasal administration of placebo (24 IU)</description>
    <arm_group_label>male placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  without past or current psychiatric or neurological disorders

        Exclusion Criteria:

          -  history of head injury

          -  medical or psychiatric illness
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keith Kendrick, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Electronic Science and Technology of China</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>School of Life Science and Technology, University of Electronic Science and Technology of China</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 9, 2018</study_first_submitted>
  <study_first_submitted_qc>September 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 26, 2019</study_first_posted>
  <last_update_submitted>September 25, 2019</last_update_submitted>
  <last_update_submitted_qc>September 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Electronic Science and Technology of China</investigator_affiliation>
    <investigator_full_name>Keith Kendrick</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>oxytocin</keyword>
  <keyword>prosocial learning</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

